A Practical Approach to Special Care in Dentistry. Группа авторов

6.1.1 Considerations for dental management.Table 6.1.2 Child–Pugh classification of cirrhosis.

      16 Chapter 6-2Table 6.2.1 Oral findings in patients with chronic kidney disease undergoing...Table 6.2.2 Considerations for dental management.Table 6.2.3 Prescription of drugs for patients with chronic kidney disease.Table 6.2.4 Clinical characteristics of chronic kidney disease.Table 6.2.5 Classification of chronic kidney disease.

      17 Chapter 7-1Table 7.1.1 Classification of mandibular cortical bone in assessment of oste...Table 7.1.2 Considerations for dental management.

      18 Chapter 7-2Table 7.2.1 Considerations for dental management.

      19 Chapter 7-3Table 7.3.1 Orofacial adverse effects of the most common biological disease‐...Table 7.3.2 Dental management considerations.Table 7.3.3 Extra‐articular manifestations of rheumatoid arthritis (excludin...

      20 Chapter 8-1Table 8.1.1 Examples of oral side‐effects of antihypertensive drugs.Table 8.1.2 Considerations for dental management.Table 8.1.3 Blood pressure categorisation in adults.Table 8.1.4 Early diagnosis of target organ damage in hypertensive patients ...Table 8.1.5 Main oral antihypertensive drugs.

      21 Chapter 8-2Table 8.2.1 Main oral adverse effects of antianginal drugs.Table 8.2.2 Considerations for dental management.Table 8.2.3 Protocol for the management of an angina pectoris attack (specif...Table 8.2.4 Classification of angina pectoris.

      22 Chapter 8-3Table 8.3.1 Main adverse oral effects of drugs administered prophylactically...Table 8.3.2 Considerations for dental management.Table 8.3.3 Clinical classification of myocardial infarction.

      23 Chapter 8-4Table 8.4.1 Main oral adverse effects of antiarrhythmic drugs.Table 8.4.2 Considerations for dental management.Table 8.4.3 Pacemaker coding system. (North American Society of Pacing and E...

      24 Chapter 8-5Table 8.5.1 Considerations for dental management.Table 8.5.2 Antimicrobial prophylaxis for preventing infective endocarditis ...

      25 Chapter 8-6Table 8.6.1 Considerations for dental management.

      26 Chapter 9-1Table 9.1.1 Considerations for dental management.Table 9.1.2 Types of respiratory failure.Table 9.1.3 GOLD (Global Initiative for Chronic Obstructive Lung Disease) st...

      27 Chapter 9-2Table 9.2.1 Considerations for dental management.Table 9.2.2 Asthma severity.Table 9.2.3 Asthma attack severity and emergency management.Table 9.2.4 Pharmacological management of asthma.

      28 Chapter 10-1Table 10.1.1 General dental management considerations.Table 10.1.2 Blood coagulation factor defects in descending order of frequen...Table 10.1.3 Severity of haemophilia (World Federation of Haemophilia 2012).Table 10.1.4 Therapeutic approaches for patients with haemophilia.Table 10.1.5 Risk factors for inhibitor development in haemophilia.Table 10.1.6 General management of patients with inhibitors.

      29 Chapter 10-2Table 10.2.1 Unfractionated heparin and low molecular weight heparin – diffe...Table 10.2.2 General dental management considerations.Table 10.2.3 Comparison of the characteristics of unfractionated heparin and...Table 10.2.4 Low molecular weight heparin (LMWH) medications.

      30 Chapter 10-3Table 10.3.1 Management of patients taking warfarin undergoing dental proced...Table 10.3.2 Major–moderate drug interactions between warfarin and antibioti...Table 10.3.3 General dental management considerations.Table 10.3.4 Pharmacokinetics and pharmacodynamics of warfarin.Table 10.3.5 Indications for oral anticoagulation and target INR.

      31 Chapter 10-4Table 10.4.1 Management of patients taking direct oral anticoagulants (DOAC...Table 10.4.2 General dental management considerations.Table 10.4.3 Direct oral anticoagulation medications^a.Table 10.4.4 Comparison of the characteristics of warfarin and direct oral a...

      32 Chapter 10-5Table 10.5.1 General dental management considerations.Table 10.5.2 Antiplatelet medications: drug characteristics.Table 10.5.3 Indications for antiplatelet therapy.

      33 Chapter 11-1Table 11.1.1 Facial features and oral manifestations of thalassaemia.Table 11.1.2 Considerations for dental management considerations.Table 11.1.3 Clinical presentation of thalassaemia.

      34 Chapter 11-2Table 11.2.1 Dental management considerations.

      35 Chapter 11-3Table 11.3.1 Dental management considerations.Table 11.3.2 Classification of neutropenia.

      36 Chapter 11-4Table 11.4.1 Dental management considerations.Table 11.4.2 Oral surgery management based on severity of thrombocytopenia.Table 11.4.3 Drugs that may impair platelet function.

      37 Chapter 11-5Table 11.5.1 Principles of oral healthcare in leukaemia.Table 11.5.2 Dental management considerations.Table 11.5.3 Classification of leukaemia.

      38 Chapter 11-6Table 11.6.1 Dental management considerations.Table 11.6.2 Features of different types of lymphomas.Table 11.6.3 Risk factors associated with the development of lymphomas.Table 11.6.4 Modified Ann Arbor staging system for lymphomas.

      39 Chapter 11-7Table 11.7.1 Dental management considerations.

      40 Chapter 12-1Table 12.1.1 Dental management considerations.Table 12.1.2 Corticosteroid supplementation regimen for patients undergoing...Table 12.1.3 Classification of glucocorticoids.Table 12.1.4 Most common therapeutic indications for systemic corticosteroi...Table 12.1.5 Most common adverse effects of systemic corticosteroids.

      41 Chapter 12-2Table 12.2.1 Guidelines for minimal haematological values for performance o...Table 12.2.2 Dental treatment planning prior to chemotherapy.Table 12.2.3 Acute oral side‐effects of chemotherapy and oral care manageme...Table 12.2.4 Chronic oral side‐effects of chemotherapy (management as for a...Table 12.2.5 Oral mucositis scales.Table 12.2.6 General dental management considerations.Table 12.2.7 Chemotherapeutic treatment intents.Table 12.2.8 Drugs used in treatment of malignant disease.Table 12.2.9 Adverse effects and toxicities of various chemotherapeutic age...

      42 Chapter 12-3Table 12.3.1 General dental management considerations.Table 12.3.2 Risk assessment and modifications in relation to specific orga...Table 12.3.3 Immunosuppressive agents used in organ transplantation and den...Table 12.3.4 Types of transplants.Table 12.3.5 Immunosuppressive regimens.Table 12.3.6 Relative potency and side‐effects of immunosuppressant drugs.Table 12.3.7 Transplanted organs, source and graft/patient survival.

      43 Chapter 13-1Table 13.1.1 Dental management considerations.Table 13.1.2 TNM staging system for oral cancer.

      44 Chapter 13-2Table 13.2.1 Acute oral complications of radiation therapy in head and neck...Table 13.2.2 Delayed oral complications of radiation therapy in head and ne...Table 13.2.3 Dental management considerations.

      45 Chapter 13-3Table 13.3.1 Dental management considerations.Table 13.3.2 Multidisciplinary approach for survivors of head and neck canc...

      46 Chapter 14-1Table 14.1.1 Dental management considerations.Table 14.1.2 Alzheimer disease – potential risk factors.Table 14.1.3 Alzheimer disease – clinical presentation.

      47 Chapter 14-2Table 14.2.1 Dental management considerations.Table 14.2.2 Diagnostic criteria for Parkinson' disease (UK Parkinson's Dis...

      48 Chapter 14-3Table 14.3.1 Dental management considerations.Table 14.3.2 McDonald criteria for the diagnosis of multiple sclerosis (201...Table 14.3.3 Clinical subtypes of multiple sclerosis.Table 14.3.4 Pharmacological treatment of multiple sclerosis.

      49 Chapter 14-4Table 14.4.1 Dental management considerations.Table 14.4.2 Main types of motor neuron diseaseTable 14.4.3 Clinical presentation of amyotrophic lateral sclerosis

      50 Chapter 14-5Table 14.5.1 Dental management considerations.Table 14.5.2 Oral healthcare for patients who have had a stroke.Table 14.5.3 Main types of stroke.Table 14.5.4 Risk factors of stroke.

      51 Chapter 15-1Table 15.1.1 Considerations for dental management.Table 15.1.2 Diagnosis for specific phobias according to the main classific...Table 15.1.3 Continuum of depth of sedation, showing the impact on the resp...Table 15.1.4 Summary of the pharmacological options for anxiety/phobia manag...Table 15.1.5 Indicator of Sedation Need (IOSN).

      52 Chapter 15-2Table 15.2.1 Considerations for dental management.Table 15.2.2 Major depressive disorder diagnostic criteria according to the...Table 15.2.3 Symptoms of depression.Table 15.2.4 Most common types of antidepressant